Pomegranate (Punica granatum) Seed Linolenic Acid Isomers: Concentration-Dependent Modulation of Estrogen Receptor Activity

REFERENCES

• Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 2007; 109:177–206.
   PubMed Web of Science ®Google Scholar
• Fatope MO, Al Burtomani SK, Takeda Y. Monoacylglycerol from Punica granatum seed oil. J Agric Food Chem 2002; 50:357–360.
   PubMed Web of Science ®Google Scholar
• Vidal A, Fallarero A, Pena BR, . Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit extracts. J Ethnopharmacol 2003; 89:295–300.
   PubMed Web of Science ®Google Scholar
• Jeune MA, Kumi-Diaka J, Brown J. Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J Med Food 2005; 8:469–475.
   PubMed Web of Science ®Google Scholar
• Lansky EP, Harrison G, Froom P, Jiang WG. Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest New Drugs 2005; 23:121–122.
   PubMed Web of Science ®Google Scholar
• Adhami VM, Mukhtar H. Anti-oxidants from green tea and pomegranate for chemoprevention of prostate cancer. Mol Biotechnol 2007; 37:52–57.
   PubMedGoogle Scholar
• Toi M, Bando H, Ramachandran C, . Preliminary studies on the antiangiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 2003; 6:121–128.
   PubMedGoogle Scholar
• Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 2006; 54:980–985.
   PubMed Web of Science ®Google Scholar
• Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 2007; 28:163–173.
   PubMed Web of Science ®Google Scholar
• Mori-Okamoto J, Otawara-Hamamoto Y, Yamato Y, Yoshimura H. Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariectomized mice. J Ethnopharmacol 2004; 92:93–101.
   PubMed Web of Science ®Google Scholar
• Newton KM, Reed SD, Grothaus L, . The herbal alternatives for menopause (HALT) study: background and study design. Maturitas 2005; 52:134–146.
   PubMed Web of Science ®Google Scholar
• Travis RC, Key TJ. Oestrogen exposure and breast cancer risk. Breast Cancer Res 2003; 5:239–247.
   PubMed Web of Science ®Google Scholar
• Foidart JM, Desreux J, Pintiaux A, Gompel A. Hormone therapy and breast cancer risk. Climacteric 2007; 2:54–61.
   Google Scholar
• Liu J, Burdette JE, Xu X, . Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001; 49:2472–2479.
   PubMed Web of Science ®Google Scholar
• Mehta R, Lansky EP. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur J Cancer Prev 2004; 13:345–348.
   PubMed Web of Science ®Google Scholar
• Kim ND, Mehta R, Yu W, . Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 2002; 71:203–217.
   PubMed Web of Science ®Google Scholar
• Choi DW, Kim JY, Choi SH, . Identification of steroid hormones in pomegranate using HPLC and GC-mass spectrometry. Food Chem 2006; 96:562–571.
   Google Scholar
• Tong P, Kasuga Y, Khoo CS. Liquid chromatographic mass spectrometric method for detection of estrogen in commercial oils and in fruit seed oils. J Food Comp Anal 2006; 19:150–156.
   Google Scholar
• Song BH, Tran HNA, Bae SY. Pomegranate (Punica granatum) as resources of phytoestrogen and anticancer substances. Kor J Microbiol Biotechnol 2007; 35:81–97.
   Google Scholar
• Sharaf A, Nigm SA. The oestrogenic activity of pomegranate seed oil. J Endocrinol 1964; 29:91–92.
   PubMedGoogle Scholar
• Yang XR, Pfeiffer RM, Garcia-Closas M, . Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. Cancer Res 2007; 67:10608–10617.
   PubMedGoogle Scholar
• Setchell KDR. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998; 68:1333S–1346S.
   PubMed Web of Science ®Google Scholar
• Setchell KDR, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999; 129:758S–767S.
   PubMed Web of Science ®Google Scholar
• Murkies AL, Wilcox G, Davis SR. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab 1998; 83:297–303.
   PubMed Web of Science ®Google Scholar
• Albertazzi P, Purdie DW. The life and times of the estrogen receptors: an interim report. Climacteric 2001; 4:194–202.
   PubMedGoogle Scholar
• Benz CC. Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol 2008; 66:65–74.
   PubMedGoogle Scholar
• Bentzon N, Düring M, Rasmussen BB, Mouridsen H, Kroman N. Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer 2008; 122:1089–1094.
   PubMed Web of Science ®Google Scholar
• Gustafsson JA. New insights in oestrogen receptor (ER) research - the ERbeta. Eur J Cancer 2000; 36:(Suppl 4):S16.
   Google Scholar
• Davis DD, Díaz-Cruz ES, Landini S, Kim YW, Brueggemeier RW. Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells. J Steroid Biochem Mol Biol 2008; 108:23–31.
   PubMed Web of Science ®Google Scholar
• Cappelletti V, Saturno G, Miodini P, Körner W, Daidone MG. Selective modulation of ER-beta by estradiol and xenoestrogens in human breast cancer cell lines. Cell Mol Life Sci 2003; 60:567–576.
   PubMedGoogle Scholar
• Nakagawa H, Kiyozuka Y, Uemura Y, . Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J Cancer Res Clin Oncol 2001; 127:258–264.
   PubMed Web of Science ®Google Scholar
• Liu J, Burdette JE, Sun Y, . Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnus-castus L. (chaste-berry). Phytomedicine 2004; 11:18–23.
   PubMed Web of Science ®Google Scholar
• Chen J, Stavro PM, Thompson LU. Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr Cancer 2002; 43:187–192.
   PubMed Web of Science ®Google Scholar
• Menendez JA, Colomer R, Lupu R. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) is a selective estrogen-response modulator in human breast cancer cells: gamma-linolenic acid antagonizes estrogen receptor-dependent transcriptional activity, transcriptionally represses estrogen receptor expression and synergistically enhances tamoxifen and ICI 182,780 (Faslodex) efficacy in human breast cancer cells. Int J Cancer 2004; 109:949–954.
   PubMed Web of Science ®Google Scholar
• Schubert SY, Lansky EP, Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol 1999; 66:11–17.
   PubMed Web of Science ®Google Scholar
• Nicolosi RJ, Rogers EJ, Kritchevsky D, Scimeca JA, Huth PJ. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 1997; 22:266–277.
   PubMedGoogle Scholar
• Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999; 34:235–241.
   PubMed Web of Science ®Google Scholar
• Arao K, Wang YM, Inoue N, . Dietary effect of pomegranate seed oil rich in 9cis, 11trans, 13cis conjugated linolenic acid on lipid metabolism in obese, hyperlipidemic OLETF rats. Lipids Health Dis 2004; 3:24–31.
   PubMedGoogle Scholar
• de Nigris F, Balestrieri ML, Williams-Ignarro S, . The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide 2007; 17:50–54.
   PubMed Web of Science ®Google Scholar
• Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyashita K, Tanaka T. Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Sci 2004; 95:481–486.
   PubMed Web of Science ®Google Scholar
• Yasui Y, Hosokawa M, Kohno H, Tanaka T, Miyashita K. Growth inhibition and apoptosis induction by all-trans-conjugated linolenic acids on human colon cancer cells. Anticancer Res 2006; 26:1855–1860.
   PubMedGoogle Scholar
• Martin TA, Das T, Mansel RE, Jiang WG. Enhanced tight junction function in human breast cancer cells by antioxidant, selenium and polyunsaturated lipid. J Cell Biochem 2007; 101:155–166.
   Google Scholar
• Nagao K, Inoue N, Wang YM, . The 10trans, 12cis isomer of conjugated linoleic acid suppresses the development of hypertension in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys Res Commun 2003; 306:134–138.
   PubMed Web of Science ®Google Scholar
• Tsuzuki T, Tokuyama Y, Igarashi M, Miyazawa T. Tumor growth suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation. Carcinogenesis 2004; 25:1417–1425.
   PubMed Web of Science ®Google Scholar
• Kohno H, Yasui Y, Suzuki R, Hosokawa M, Miyashita K, Tanaka T. Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxmethan-induced rat colon carcinogenesis through elevation of colonic PPAR expresion and alteration of lipid composition. Int J Cancer 2004; 110: 896–901.
   PubMedGoogle Scholar
• Igarashi M, Miyazawa T. Newly recognized cytotoxic effect of conjugated trienoic fatty acids on cultured human tumor cells. Cancer Lett 2000; 148:173–9.
   PubMed Web of Science ®Google Scholar
• Miki Y, Suzuki T, Nagasaki S, Hata S, Akahira J, Sasano H. Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene. J Steroid Biochem Mol Biol 2009; 113:281–289.
   PubMedGoogle Scholar